
Opinion|Videos|July 2, 2024
Key Takeaways on the Evolving NMIBC Treatment Landscape
The panel concludes by offering key takeaways on the evolving treatment landscape for BCG-unresponsive non–muscle invasive bladder cancer.
Advertisement
Video Player is loading.
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial launches of neuromodulation therapy for erectile dysfunction after radical prostatectomy
2
PROSTOX ultra launches on US market following new data presented at ASTRO 2025
3
Andrea B. Apolo, MD, discusses survival gains with EV/pembrolizumab in bladder cancer
4
Rectal diazepam eases instillation of nadofaragene firadenovec in NMIBC
5